"This innovative service will help us deliver our promise of empowering individuals through better understanding their strengths and challenges"
Mike Dalby, AXA Health Distribution Director
The benefit will be available to add to corporate schemes at renewal, from early October 2022, and includes eligible family members (seven years and above). Onward support includes medication reviews for ADHD, post-assessment group sessions for autism and ADHD, as well as educational guidance.
Mike Dalby, Distribution Director, AXA Health said: “We’re really excited to launch this new service and help our clients support their neurodivergent talent, as well as their employees whose family members require neurodevelopmental assessments.
“This innovative service will help us deliver our promise of empowering individuals through better understanding their strengths and challenges and enable workplaces to create inclusive and supportive environments where people can thrive and be themselves.”
“Working with ProblemShared will enable us to support members through the process, from initial assessment to diagnosis and support sessions, in a flexible way that works for them.”